Stay updated on Atezolizumab Subq in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab Subq in NSCLC: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page, with its footer revision label updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:12:01.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:13:37.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating restricted access to the page. Visible additions include the 403 text and a Home link, while the previous detailed study content and navigation elements have been removed.
    Difference
    19%
    Check dated 2026-09-20T19:45:03.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now includes a mention of the 2018 NIH Grant/Contract and updates the revision to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-30T21:42:42.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page now displays a generic 'An error occurred' message and HTML, replacing the previous study record content. This indicates a temporary outage or server error rather than an update to the study data.
    Difference
    18%
    Check dated 2026-08-09T09:16:29.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.3 to v3.6.4, indicating a minor update to the page's version metadata. This update does not alter any study details, eligibility criteria, or results on the page.
    Difference
    0.0%
    Check dated 2026-07-25T23:52:33.000Z thumbnail image

Stay in the know with updates to Atezolizumab Subq in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.